Long-term dienogest treatment in endometriosis: Consensus from Taiwanese experts.
Journal
Taiwanese journal of obstetrics & gynecology
Journal Volume
63
Journal Issue
6
Start Page
823
End Page
825
ISSN
1875-6263
Date Issued
2024-11
Author(s)
Liu, Jah-Yao
Chang, Cherry Yin-Yi
Yen, Chih-Feng
Wu, Meng-Hsing
Chen, Yi-Jen
Lai, Tsung-Hsuan
Lan, Kuo-Chung
Cheng, Ya-Min
Tsai, Yung-Chieh
Law, Kim Seng
Wu, Wen-Yih
Chen, San-Nung
Abstract
Dienogest has been proven effective as long-term therapeutic option for pelvic pain caused by endometriosis. However, in Taiwan, there is a lack of a well-tailored consensus on its long-term administration. To address this gap, Taiwanese experts in collaboration with the Taiwan Endometriosis Society (TES), convened to provide structured recommendations on dienogest treatment and monitoring strategies. Drawing from clinical evidence and collective expertise, the experts formulated individualized treatment strategies based on treatment objectives and the patient's demographics. The experts recommend long-term dienogest administration for endometriosis patients for appropriate symptom control while reducing the risk of disease recurrence. Specifically, they recommend regular ultrasound examinations and relevant blood tests to monitor disease progression and therapeutic response with additional breast screening for patients at high risk for breast cancer. These recommendations aim to provide physicians with comprehensive guidance on the long-term administration of dienogest for endometriosis, ensuring patient safety and optimizing treatment outcomes.
Type
editorial